$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000101008617000008 Filed on May 04, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$4.265M	$5.202M	$1.300M
YoY Change	124.47%	300.15%	8.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.058M	$2.870M	$2.656M
YoY Change	-18.21%	8.06%	-13.99%
% of Gross Profit
Research & Development	$5.068M	$6.360M	$2.536M
YoY Change	71.91%	150.79%	-9.78%
% of Gross Profit
Depreciation & Amortization	$39.66K	$36.00K	$44.45K
YoY Change	-9.01%	-19.01%	-43.57%
% of Gross Profit
Operating Expenses	$8.323M	$9.471M	$8.329M
YoY Change	-25.6%	13.71%	33.66%
Operating Profit	-$4.059M	-$4.269M	-$7.059M
YoY Change	-56.28%	-39.52%	40.06%
Interest Expense	$3.652M	$3.609M	$0.00
YoY Change	35659.7%		-100.0%
% of Operating Profit
Other Income/Expense, Net	$8.066K	$4.419K	$11.31K
YoY Change	-86.21%	-60.93%	107.01%
Pretax Income	$7.400M	$8.500M	$10.40M
YoY Change	-22.92%	-18.27%	46.48%
Income Tax	$92.83K	$115.1K	$11.29K
% Of Pretax Income	1.25%	1.35%	0.11%
Net Earnings	-$7.501M	-$8.615M	-$10.45M
YoY Change	-21.59%	-17.55%	46.08%
Net Earnings / Revenue	-175.87%	-165.61%	-803.77%
Basic Earnings Per Share
Diluted Earnings Per Share	-$95.18K	-$109.1K	-$192.2K
COMMON SHARES
Basic Shares Outstanding	78.78M shares	78.78M shares	54.11M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.90M	$30.10M	$104.1M
YoY Change	-60.38%	-71.09%	9.01%
Cash & Equivalents	$30.87M	$30.10M	$104.1M
Short-Term Investments
Other Short-Term Assets	$10.90M	$11.00M	$600.0K
YoY Change	419.05%	1733.33%	-91.04%
Inventory	$15.42M	$19.12M	$22.84M
Prepaid Expenses
Receivables	$1.769M	$4.879M	$1.003M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$58.95M	$65.17M	$128.5M
YoY Change	-58.94%	-49.27%	-2.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$263.0K	$263.3K	$413.8K
YoY Change	-29.46%	-36.38%	-45.05%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$642.1K	$642.1K	$1.990M
YoY Change	0.08%	-67.73%	0.0%
Total Long-Term Assets	$97.08M	$95.65M	$56.34M
YoY Change	67.1%	69.78%	34.36%
TOTAL ASSETS
Total Short-Term Assets	$58.95M	$65.17M	$128.5M
Total Long-Term Assets	$97.08M	$95.65M	$56.34M
Total Assets	$156.0M	$160.8M	$184.8M
YoY Change	-22.63%	-12.97%	6.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.475M	$2.259M	$8.494M
YoY Change	-64.96%	-73.4%	139.04%
Accrued Expenses	$3.098M	$2.948M	$5.045M
YoY Change	-6.43%	-41.56%	47.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.63M	$12.56M	$13.54M
YoY Change	-93.71%	-7.22%	94.05%
LONG-TERM LIABILITIES
Long-Term Debt	$68.80M	$67.70M	$0.00
YoY Change
Other Long-Term Liabilities	$376.7M	$376.4M	$465.7M
YoY Change	30.53%	-19.18%	12.76%
Total Long-Term Liabilities	$445.5M	$444.1M	$465.7M
YoY Change	54.37%	-4.64%	12.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.63M	$12.56M	$13.54M
Total Long-Term Liabilities	$445.5M	$444.1M	$465.7M
Total Liabilities	$459.4M	$457.0M	$479.5M
YoY Change	-9.16%	-4.7%	12.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$517.3M	-$509.8M	-$471.9M
YoY Change	7.44%	8.02%	9.96%
Common Stock	$213.8M	$213.6M	$177.2M
YoY Change	20.56%	20.54%	0.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$303.4M	-$296.1M	-$294.7M
YoY Change
Total Liabilities & Shareholders Equity	$156.0M	$160.8M	$184.8M
YoY Change	-22.63%	-12.97%	6.67%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$7.501M	-$8.615M	-$10.45M
YoY Change	-21.59%	-17.55%	46.08%
Depreciation, Depletion And Amortization	$39.66K	$36.00K	$44.45K
YoY Change	-9.01%	-19.01%	-43.57%
Cash From Operating Activities	-$1.680M	-$933.0K	-$8.641M
YoY Change	-93.55%	-89.2%	40.09%
INVESTING ACTIVITIES
Capital Expenditures	-$40.00K	$0.00	$8.475K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$40.00K	$0.00	-$8.475K
YoY Change		-100.0%	-100.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$0.00
YoY Change			-100.0%
Cash From Financing Activities	-60.00K	-$193.1K	$0.00
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-1.680M	-$933.0K	-$8.641M
Cash From Investing Activities	-40.00K	$0.00	-$8.475K
Cash From Financing Activities	-60.00K	-$193.1K	$0.00
Net Change In Cash	-1.780M	-$1.126M	-$8.650M
YoY Change	-93.16%	-86.98%	107.51%
FREE CASH FLOW
Cash From Operating Activities	-$1.680M	-$933.0K	-$8.641M
Capital Expenditures	-$40.00K	$0.00	$8.475K
Free Cash Flow	-$1.640M	-$933.0K	-$8.650M
YoY Change	-93.7%	-89.21%	40.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78780059	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
CY2017Q1	dei	Trading Symbol TradingSymbol	SIGAQ
CY2011Q2	siga	Amountofoptiontobereceivedfrom Bard Aforapprovalforextensionof84mothexpiry AmountofoptiontobereceivedfromBARDAforapprovalforextensionof84mothexpiry	50000000	USD
CY2016Q4	siga	Computer Equipment ComputerEquipment	770479	USD
CY2017Q1	siga	Computer Equipment ComputerEquipment	762604	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2011Q2	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	122700000	USD
CY2011Q2	siga	Holdbackamountpending Fd Aapproval HoldbackamountpendingFDAapproval	102500000	USD
CY2016Q1	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	0	USD
CY2017Q1	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	626209	USD
CY2017Q1	siga	Increaseto Fundingof Researchand Development Contract IncreasetoFundingofResearchandDevelopmentContract	10100000	USD
CY2016Q1	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	0	USD
CY2017Q1	siga	Interest Paidon Term Loan From Restricted Cash InterestPaidonTermLoanFromRestrictedCash	-2527778000	USD
CY2015Q1	siga	Inventory Write Downs InventoryWriteDowns	686000	USD
CY2017Q1	siga	Number Of Active Grants NumberOfActiveGrants	1	grant
CY2017Q1	siga	Numberof Coursestobe Deliveredby Company NumberofCoursestobeDeliveredbyCompany	467000	course
CY2016Q1	siga	Patent Preparation Fees PatentPreparationFees	219715	USD
CY2017Q1	siga	Patent Preparation Fees PatentPreparationFees	240597	USD
CY2016Q1	siga	Paymentof Interest Expense PaymentofInterestExpense	0	USD
CY2017Q1	siga	Paymentof Interest Expense PaymentofInterestExpense	-2527778	USD
CY2017Q1	siga	Potential Future Aggregate Research And Development Expenses PotentialFutureAggregateResearchAndDevelopmentExpenses	17500000	USD
CY2011Q2	siga	Reducedholdbackamount Reducedholdbackamount	41000000	USD
CY2016	siga	Reducedholdbackamount Reducedholdbackamount	41000000	USD
CY2016Q1	siga	Reorganization Payments ReorganizationPayments	1500000	USD
CY2016Q1	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1698228	USD
CY2017Q1	siga	Reorganization Professional Fees ReorganizationProfessionalFees	0	USD
CY2016Q1	siga	Reorganization Trusteefees ReorganizationTrusteefees	13000	USD
CY2017Q1	siga	Reorganization Trusteefees ReorganizationTrusteefees	0	USD
CY2016Q1	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1269733	USD
CY2017Q1	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	5201786	USD
CY2017Q1	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	4700000	USD
CY2016Q1	siga	Restricted Stock Units RestrictedStockUnits	363337	shares
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2517072	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2259096	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3154370	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4878631	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2357194	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	307256	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44452	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	36175	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	626209000	USD
CY2017Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	676580	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4584752	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2948349	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	481641	USD
CY2017Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	393252	USD
CY2016Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	262664	USD
CY2017Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	312414	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3468266	USD
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3496565	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	213714154	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	213608687	USD
CY2016Q4	us-gaap	Assets Assets	160981977	USD
CY2017Q1	us-gaap	Assets Assets	160820485	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	69159474	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	65172653	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112711028	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104061350	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28701824	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30103574	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8649678	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1401750	USD
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.29
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78692612	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78780059	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78692612	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78780059	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	7869	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	7878	USD
CY2017Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	115000000000	USD
CY2016Q1	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1677945	USD
CY2017Q1	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	0	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	72649277	USD
CY2017Q1	us-gaap	Deferred Costs DeferredCosts	79038559	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	215825	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8719141	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	367483905	USD
CY2017Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	376203046	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	286066	USD
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455220	USD
CY2017Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455220	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	99207	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	6389282	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	12252	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6727409000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7353618000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21190	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10394773	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7090409	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2673576	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1724261	USD
CY2016Q1	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	2903332	USD
CY2017Q1	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	0	USD
CY2016Q1	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	2917187	USD
CY2017Q1	us-gaap	Litigation Settlement Interest LitigationSettlementInterest	0	USD
CY2016Q4	us-gaap	Loans Payable LoansPayable	66553053	USD
CY2017Q1	us-gaap	Loans Payable LoansPayable	67661969	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2016Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2017Q1	us-gaap	Goodwill Goodwill	898334	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	8500000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10437273	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8499876	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11294	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	115070	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6205732	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1894379	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-21057	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-22165	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-71367	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-22423	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	0	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	3608916	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7293880	USD
CY2017Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5758087	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	26209964	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	19119555	USD
CY2016Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	18916084	USD
CY2017Q1	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	13361468	USD
CY2016Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542044	USD
CY2017Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542043	USD
CY2016Q4	us-gaap	Liabilities Liabilities	448400246	USD
CY2017Q1	us-gaap	Liabilities Liabilities	456959158	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	160981977	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	160820485	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13829233	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12561063	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4269170	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1483253	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1566103	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642083	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6360490	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10138890	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10138890	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17333332	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	14805554	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-501140292	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-509755238	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2656231	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-193052	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8475	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8641203	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1594802	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-10448567	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-8614946	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11311	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4419	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	8329144	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	9470956	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7059411	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	247989	USD
CY2017Q1	us-gaap	Other Liabilities OtherLiabilities	225824	USD
CY2016Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
CY2017Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	1108916	USD
CY2016Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	217000000	USD
CY2016Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2017Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	193052	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8475	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	954426	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	932003	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3767743	USD
CY2017Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3759867	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	299477	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	263302	USD
CY2016Q1	us-gaap	Reorganization Items ReorganizationItems	3389173	USD
CY2017Q1	us-gaap	Reorganization Items ReorganizationItems	0	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2536011	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2869869	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	195865	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	87594	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-287418269	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	-296138673	USD
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6727409	USD
CY2017Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7353618	USD
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54114296	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78777144	shares

Files In Submission

Name	View Source	Status
0001010086-17-000008-index-headers.html	Edgar Link	pending
0001010086-17-000008-index.html	Edgar Link	pending
0001010086-17-000008.txt	Edgar Link	pending
0001010086-17-000008-xbrl.zip	Edgar Link	pending
exhibit101modification0012.htm	Edgar Link	pending
exhibit102modification0014.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20170331.xml	Edgar Link	completed
siga-20170331.xsd	Edgar Link	pending
siga-20170331x10q.htm	Edgar Link	pending
siga-20170331_cal.xml	Edgar Link	unprocessable
siga-20170331_def.xml	Edgar Link	unprocessable
siga-20170331_lab.xml	Edgar Link	unprocessable
siga-20170331_pre.xml	Edgar Link	unprocessable
siga-exhibit3112017q1.htm	Edgar Link	pending
siga-exhibit3122017q1.htm	Edgar Link	pending
siga-exhibit3212017q1.htm	Edgar Link	pending
siga-exhibit3222017q1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2017 Q2 Form 10-Q Financial Statement

#000101008617000008 Filed on May 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2017 Q2 Form 10-Q Financial Statement

#000101008617000008 Filed on May 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga